The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: a secondary study from the WHICH randomized clinical trial.
South Africa
Chanel Avenant, Mandisa Singata-Madlik, Alexis J. Bick, Donita Africander, Yusentha Balakrishna, Karl-Heinz Storbeck, Johnson Mosoko Moliki, Sigcinile Dlamini, Salndave Skosana, Jenni Smit, Mags Beksinska, Ivana Beesham, Ishen Seocharan, Joanne Batting, G Justus Hofmeyr, Janet P. Hapgood
Created on
April 09, 2024
Last modified
April 09, 2024
Page views
3406
Documentation in PDF
Metadata
DDI/XML
JSON
- Data files
- Testosterone
PPD0&25W_arm (PPD025W_arm)
Data file: Testosterone
Overview
Valid:
436
Invalid:
0
Type:
Discrete
Width:
33
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| DMPA-IM | 183 |
42%
|
|
| NET-EN | 149 |
34.2%
|
|
| excluded non-study D0 or 25W | 94 |
21.6%
|
|
| excluded not receive 6M injection | 10 |
2.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.